Viewing Study NCT06669234


Ignite Creation Date: 2025-12-25 @ 2:25 AM
Ignite Modification Date: 2025-12-28 @ 12:08 AM
Study NCT ID: NCT06669234
Status: RECRUITING
Last Update Posted: 2025-11-25
First Post: 2024-10-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 1 Safety and Tolerability Study of ALN-F1202 in Healthy Adults
Sponsor: Regeneron Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module